Home | All results_reference

[RDF data]
Results Reference #10025

Resource URI: http://static.linkedct.org/resource/results_reference/10025
linkedct:PMid 9704735
linkedct:citation McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol. 1998 Aug;16(8):2825-33.
rdfs:label Results Reference #10025
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00168740>
linkedct:results_reference_id 10025 (xsd:int)
rdf:type linkedct:results_reference